Form 4: CONMED Corp Executive Peter K. Shagory Reports Stock Transactions
SEC Form 4 Filing
EVP Peter K. Shagory reports acquisition and disposal of CONMED Corp stock and stock appreciation rights on March 14, 2025.
Summary
- On March 14, 2025, Peter K. Shagory, EVP of Strategy & Corporate Development at CONMED Corp, reported transactions involving the company's stock.
- Shagory acquired 4,500 shares of common stock at a price of $55.42.
- He also disposed of 4,316 shares of common stock at a price of $58.83.
- Following these transactions, Shagory beneficially owns 3,896.635 shares of common stock.
- Additionally, Shagory exercised 4,500 Stock Appreciation Rights (SARs) with an exercise price of $55.42, which were granted under the company's 1999 Amended and Restated Long-Term Incentive Plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by an executive, with neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of company executives and their potential impact on the stock.
Stakeholder Impact
- The reported transactions may influence investor sentiment regarding CONMED Corp's stock.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of stock and derivative security transactions. |
| 03/17/2025 | Date of signature for the Form 4 filing. |
| 05/11/2025 | Expiration date of the Stock Appreciation Rights. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.